Evidence map›Paper›PMID 29266212›Full record

ArticleClinical genetics2018

Diagnostic exome sequencing in children: A survey of parental understanding, experience and psychological impact.

J Wynn, R Ottman, J Duong, A L Wilson, P Ahimaz, J Martinez, R Rabin, E Rosen, R Webster, C Au and 12 more

Abstract read
In one paragraph

Article in Clinical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. The value of large-scale programmes in human genomics.European journal of human genetics : EJHG · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Newborn screening for neurodevelopmental diseases: Are we there yet?American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

J WynnDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.ORCID 0000-0002-5220-6022
R OttmanG.H. Sergievsky Center and Departments of Epidemiology and Neurology, Columbia University Medical Center and NY State Psychiatric Institute, New York, New York.
J DuongDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, New York.
A L WilsonDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
P AhimazDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
J MartinezDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
R RabinCollege of Liberal Arts and Sciences, Long Island University - Post Campus, Brookville, New York.
E RosenCollege of Liberal Arts and Sciences, Long Island University - Post Campus, Brookville, New York.
R WebsterColumbia University Medical School, New York, New York.
C AuDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
M T ChoDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
C EganDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
E GuzmanDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
M PrimianoDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
J E ShawDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
R SissonDivision of Clinical Genetics, Department of Pediatrics, New York Presbyterian Hospital, Columbia University, New York, New York.
R L KlitzmanDepartment of Psychiatry, Columbia University Medical Center and NY State Psychiatric Institute, New York, New York.
P S AppelbaumDepartment of Psychiatry, Columbia University Medical Center and NY State Psychiatric Institute, New York, New York.
U Lichter-KoneckiDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
K Anyane-YeboaDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
A IglesiasDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
W K ChungDivision of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York.
Columbia University Irving Medical Center · USNewYork–Presbyterian Hospital · USLong Island University · USColumbia University · US

Funding

Center for Research on the Ethical, Legal and Social Implications of Psychiatric, Neurologic and Behavioral GeneticsP50HG007257 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI APPELBAUM, PAUL STUART · 2013 to 2017
$5.4M
Center for Research on Ethical, Legal & Social Implications of Psychiatric, Neurologic & Behavioral GeneticsRM1HG007257 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI APPELBAUM, PAUL STUART · 2018 to 2021
$4.4M
Impact of return of incidental genetic test results to research participants in tR01HG006600 · NHGRI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHUNG, WENDY K, PHELAN, JO C · 2011 to 2013
$2.1M
NHGRI NIH HHS P50 HG007257NHGRI NIH HHS R01 HG006600NHGRI NIH HHS RM1 HG007257
6 · The paper itself

Abstract

Clinical exome sequencing (CES) is increasingly being used as an effective diagnostic tool in the field of pediatric genetics. We sought to evaluate the parental experience, understanding and psychological impact of CES by conducting a survey study of English-speaking parents of children who had diagnostic CES. Parents of 192 unique patients participated. The parent's interpretation of the child's result agreed with the clinician's interpretation in 79% of cases, with more frequent discordance when the clinician's interpretation was uncertain. The majority (79%) reported no regret with the decision to have CES. Most (65%) reported complete satisfaction with the genetic counseling experience, and satisfaction was positively associated with years of genetic counselor (GC) experience. The psychological impact of CES was greatest for parents of children with positive results and for parents with anxiety or depression. The results of this study are important for helping clinicians to prepare families for the possible results and variable psychological impact of CES. The frequency of parental misinterpretation of test results indicates the need for additional clarity in the communication of results. Finally, while the majority of patients were satisfied with their genetic counseling, satisfaction was lower for new GCs, suggesting a need for targeted GC training for genomic testing.

Indexed as

Genetic CounselingAdultChildDevelopmental DisabilitiesDisclosureExomeExome SequencingFemaleGenetic TestingHumansMaleParentsSurveys and Questionnairesexome sequencinggenetic counselinggenomic medicineparental experiencepsychological impact

Identifiers

PMID29266212
PMCPMC5899627
OpenAlexW2932120605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.